Patents Assigned to DSRCo BV
  • Patent number: 12623011
    Abstract: Systems and methods for performing Direct Sodium Removal (DSR) therapy are provided in which an implantable device includes a pump coupled to an inlet catheter designed for placement in a patient's peritoneal cavity, an outlet catheter designed to be coupled to the patient's bladder, and is operably coupled to an analyte sensor, the pump programmed to transfer and/or cease transfer of fluid from the patient's peritoneal cavity to the patient's bladder for voiding responsive to a level of analyte detected by the analyte sensor. In addition, the system may include a processor that computes an amount of analyte transferred per pumping session.
    Type: Grant
    Filed: October 6, 2022
    Date of Patent: May 12, 2026
    Assignee: DSRCo BV
    Inventors: Ian Crosbie, Andreas Wirth, Oliver Goedje
  • Patent number: 12496384
    Abstract: A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
    Type: Grant
    Filed: December 15, 2023
    Date of Patent: December 16, 2025
    Assignee: DSRCo BV
    Inventors: Jeffrey Testani, Christopher McIntyre, Ian Crosbie, Oliver Goedje